Who owns Protara Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of TARA from SEC Form 13F filings across 119 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 119 institutions disclosed 46.5M shares of Protara Therapeutics, Inc. worth $141.8M — about 74% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
119
13F holders
$141.8M
value, 2026 filers
74%
of shares outstanding (46.5M sh)
20
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of TARA's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 3.7M | $11.3M | 0.0% | 5.9% | +1.2% |
| 2 | MILLENNIUM MANAGEMENT LLC | 3.1M | $9.4M | 0.0% | 4.9% | -0.1% |
| 3 | Velan Capital Investment Management LP | 2.8M | $8.7M | 8.3% | 4.5% | 0.0% |
| 4 | Rosalind Advisors, Inc.NEW | 2.4M | $7.3M | 2.3% | 3.8% | new |
| 5 | Blackstone Inc. | 2.4M | $7.2M | 0.0% | 3.8% | +4.5% |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | 2.3M | $7.0M | 0.0% | 3.7% | 0.0% |
| 7 | CITADEL ADVISORS LLC | 2.1M | $6.4M | 0.0% | 3.3% | +69.4% |
| 8 | Sio Capital Management, LLC | 2.0M | $6.1M | 1.1% | 3.2% | +3.6% |
| 9 | BAKER BROS. ADVISORS LP | 1.8M | $5.6M | 0.0% | 2.9% | +89.8% |
| 10 | ACORN CAPITAL ADVISORS, LLC | 1.8M | $5.3M | 1.5% | 2.8% | 0.0% |
| 11 | MARSHALL WACE, LLP | 1.5M | $4.7M | 0.0% | 2.5% | +120.1% |
| 12 | 5AM Venture Management, LLC | 1.4M | $4.2M | 1.4% | 2.2% | 0.0% |
| 13 | GEODE CAPITAL MANAGEMENT, LLC | 1.3M | $4.1M | 0.0% | 2.1% | +0.5% |
| 14 | Integral Health Asset Management, LLC | 1.3M | $3.8M | 0.2% | 2% | -16.7% |
| 15 | Qube Research & Technologies Ltd | 1.2M | $3.6M | 0.0% | 1.9% | +11.8% |
| 16 | AMERIPRISE FINANCIAL INC | 1.1M | $3.4M | 0.0% | 1.8% | +1890.2% |
| 17 | STATE STREET CORP | 1.0M | $3.2M | 0.0% | 1.7% | -1.9% |
| 18 | Palo Alto Investors LPNEW | 1.0M | $3.2M | 0.5% | 1.6% | new |
| 19 | Balyasny Asset Management L.P. | 1.0M | $3.1M | 0.0% | 1.6% | -2.3% |
| 20 | Walleye Capital LLC | 933,246 | $2.8M | 0.0% | 1.5% | +84.6% |
| 21 | BANK OF AMERICA CORP /DE/ | 919,340 | $2.8M | 0.0% | 1.5% | +4.2% |
| 22 | ADAR1 Capital Management, LLC | 850,512 | $2.6M | 0.1% | 1.4% | -9.6% |
| 23 | DIMENSIONAL FUND ADVISORS LP | 684,093 | $2.1M | 0.0% | 1.1% | +0.1% |
| 24 | NORTHERN TRUST CORP | 536,426 | $1.6M | 0.0% | 0.9% | -2.9% |
| 25 | RENAISSANCE TECHNOLOGIES LLC | 531,830 | $1.6M | 0.0% | 0.8% | +111.5% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.